Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies.
Layal Antoury, Ningyan Hu, Leonora Balaj...
https://pubmed.ncbi.nlm.nih.gov/30254196/Actively Recruiting
Led by Massachusetts General Hospital · Updated on 2026-11-03
64
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are studying myotonic dystrophy type 1 to find less invasive ways to measure disease activity and severity. Current methods often require muscle biopsies, which can be uncomfortable and invasive. This research aims to explore whether urine and blood samples, along with muscle function tests, can provide useful information about this condition. The study is observational and seeks to improve understanding, diagnosis, and treatment approaches for myotonic dystrophy. Participants will provide urine and blood samples and undergo muscle function testing. These samples and tests will be used to analyze metabolomic biomarkers that could reflect the diseases activity without needing muscle tissue biopsies. The study includes both individuals diagnosed with myotonic dystrophy and unaffected participants to compare findings over time. Throughout the study, participants will be monitored and assessed at regular intervals for up to five years. Researchers will measure extracellular vesicle metabolite profiles as the primary outcome to evaluate disease markers. Participants involvement includes providing samples and undergoing muscle tests, with ongoing data collection to enhance knowledge about myotonic dystrophy and support future improvements in care and treatment.
CONDITIONS
Metabolomic Biomarkers of Myotonic Dystrophy
T
Tamkin Shahraki, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Massachusetts General Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants provide urine and blood samples and perform muscle function tests to help researchers study disease markers over time.
Regular visits for sample collection and testing
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Layal Antoury, Ningyan Hu, Leonora Balaj...
https://pubmed.ncbi.nlm.nih.gov/30254196/Preeti Kumari, Lauren M Sullivan, Zhaozhi Li...
https://pubmed.ncbi.nlm.nih.gov/40044661/Layal Antoury, Ningyan Hu, Basil Darras...
https://pubmed.ncbi.nlm.nih.gov/31211175/Massachusetts General Hospital
Lead Sponsor